[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cervical-tumor\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cervical-tumor":33},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":36,"overallStatus":49,"whyStopped":4,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":5},"100393503","the-role-of-micrometastasis-and-isolated-tumor-cells-itcs-in-endometrial-and-cervical-cancer-a-multicenter-study-100393503",false,"NCT04403867","The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.","The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Uterine Cancers (Endometrial\u002FCervical) Submitted to Sentinel Lymph Nodes (SLN) Procedure: an Observational Study","ITCMicroUtCa","Inclusion Criteria:\n\n* Early stage endometrial cancer scheduled for SLN procedure\n* Early stage cervical cancer scheduled for SLN procedure\n* Pathological evaluation of SLNs with standard ultra-staging or one-step nucleic acid amplification (OSNA) for the detection of metastasis\n* Presence of lymph nodes metastasis (macrometastasis or low volume disease \\[micrometastasis and isolated tumor cells\\])\n\nExclusion Criteria:\n\n* Previous (\\\u003C5 years) or concomitant malignancy other than non-melanoma skin cancer\n* Advanced\u002Fmetastatic endometrial cancer\n* Locally advanced\u002Fmetastatic cervical cancer","FEMALE","18 Years",{"count":20,"type":21},500,"ESTIMATED","OBSERVATIONAL","The role of small-volume lymph node disease (ITC and micro metastases) among patients with endometrial or cervical cancer submitted to sentinel node (SLN) procedure is not clearly defined.\n\nThis study was designed to create a dataset of patients with lymph nodal disease. Data on type and volume of lymph nodal disease, therapeutic choices and oncological outcomes (DFS, OS, recurrence rate) will be collected and analyzed.\n\nThis will allow to define the groups of patients who may need or for whom it can be avoided any adjuvant treatment on the basis of lymph node status.",[25,26,27,28,29,30,31,32,33,34,35],"Endometrial Cancer","Cervical Cancer","Sentinel Lymph Node","Micrometastasis","Sentinel Lymph Node Biopsy","Endometrium Tumor","Endometrial Neoplasms","Cervical Neoplasm","Cervical Tumor","Lymph Node Metastases","Lymph Node Disease",[37,38,39,40,41,42,43,44,45,46,47,48],"endometrial cancer","cervical cancer","sentinel lymph node","low volume disease","survival","recurrence rate","adjuvant therapy","micrometastases","isolated tumor cell","macrometastases","ultrastaging","one-step nucleic acid amplification (OSNA)","RECRUITING","2022-08-15",{"date":52,"type":53},"2022-08-17","ACTUAL",{"date":55,"type":53},"2020-01-02",{"date":57,"type":21},"2027-01",{"name":59,"class":60},"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","OTHER"]